Research Reports

Healthcare

icon
Home » Reports » Anti Viral Drug Market Global Historical Growth 2012 2016 Future Outlook 2017 2024 Demand Analysis Opportunity Evaluation
Market Research Report

Anti-Viral Drug Market : Global Historical Growth (2012-2016) & Future Outlook (2017-2024) Demand Analysis & Opportunity Evaluation

Published On : 09:07 AM, 3rd October, 2018 REP-ID-473 Category: Healthcare

Anti-Viral Drug Market Overview

Anti-viral drugs refer to the class of antimicrobials which are used specifically for the treatment of viral infections. Anti-viral drugs are formulated to treat HIV, hepatitis virus, influenza and herpes virus. These anti-viral drugs can be used only for specific disease.

Market Size and Forecast

Global ant-viral drug market is anticipated to flourish at a CAGR of 5.9% over the forecast period. Further, the market of anti-viral drugs accounted for USD 31.2 Billion in 2016 and is projected to garner USD 42.3 billion by the end of 2024. Rising prevalence of viral infections and diseases across the globe is expected to increase the demand for anti-viral drugs globally.

Anti-Viral Drugs

In the regional platform, North America dominated the overall market of anti-viral drugs in 2016. Further, North America market is expected to continue its dominance over the forecast period on the account of rising healthcare expenditure. Additionally, presence of highly developed healthcare infrastructure and rising awareness about the viral infections is expected to fuel the growth of anti-viral drugs market in the North America region. U.S. is expected to be the major contributor to the growth of anti-viral drugs owing to the presence of major key players.

Asia Pacific is anticipated to witness robust growth over the forecast period 2017-2024. This growth can be attributed to the increasing number of virus infected people and rising disposable income of the population. Additionally, rising medical tourism in the region is projected to supplement the growth of the anti-viral drugs market. Developing economies such as China, India are the major countries witnessing the augmented demand for anti-viral drugs. Further, favorable government regulations boosting the growth of healthcare sector in the region is likely to swell the demand for anti-viral drugs. Middle East & Africa anti-viral drugs market is expected to grow at a significant pace during the forecast period. In 2016, 25.6 Million people were estimated to be living with HIV. This factor is anticipated to trigger the growth of anti-viral drugs market in Middle East & Africa region. The demand for anti-viral drugs in Latin America is forecasted to increase in the upcoming years. High number of deaths caused from viral diseases is predicted to garner the growth of anti-viral drugs in the Latin America region. On the basis of type, anti-viral drug market is further segmented into generic drugs and branded drugs. Generic drugs accounted for the largest percentage of market share in overall anti-viral drug market. Further, this segment is anticipated to witness highest CAGR during the forecast period.

Market Segmentation

Our in-depth analysis has segmented global anti-viral drug market into the following segments:

By Type

  • Generic Drugs
  • Branded Drugs

Anti-viral Drugs market

By Application

  • HIV Treatment
  • Hepatitis Treatment
  • Herpes Treatment
  • Influenza Treatment
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Region

Global anti-viral drug market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, South Korea & Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (GCC, North Africa, South Africa & Rest of Middle East and Africa) Market Size and Y-O-Y Growth Analysis

Growth Drivers & Challenges

Rising number of HIV cases is expected to be one of the key growth drivers for anti-viral drugs market. Further, rising awareness about this deadly diseases are substantially raising the demand for the anti-viral drugs globally. According to WHO, the number of people infected with HIV were estimated to be 36.7 Million in 2016. Additionally, 1.8 Million new cases of HIV were registered in 2016. This high growth in the number of HIV cases is believed to garner the growth of global anti-viral drugs market. Furthermore, research & development associated with the anti-viral drugs market is expected to drive the growth of the anti-viral drugs market globally. Apart from this, favorable government healthcare regulations are envisioned to bolster the growth of the global anti-viral drugs market. In contrast, high cost of advanced developing anti-viral drugs is anticipated to restrain the development of anti-viral drugs market. Further, lack of awareness about the viral diseases is expected to limit the growth of the global anti-viral drug market.

Key Players

  • GlaxoSmithKline PLC
    • Company Overview
    • Key Product Offerings
    • Business Strategy
    • SWOT Analysis
    • Financials 
  • Johnson and Johnson
  • Merck & Co
  • Abbott Laboratories
  • Cipla Limited
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers-Squibb
  • Gilead Sciences
  • Aurobindo Pharma
  • Sino Biopharmaceutical

Things to know

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com


UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Subscribe To Our Newsletters

Copyright © 2018 Research Nester. All rights reserved

Top